Press "Enter" to skip to content

Patent delisted for Boehringer Ingelheim drug OFEV

0
Copyright © DrugPatentWatch. Originally published at Patent delisted for Boehringer Ingelheim drug OFEV

Annual Drug Patent Expirations for OFEV
Ofev is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from one supplier. There are five patents protecting this drug and one Paragraph IV challenge.

This drug has two hundred and twelve patent family members in fifty-one countries.

The generic ingredient in OFEV is nintedanib esylate. One supplier is listed for this compound. Additional details are available on the nintedanib esylate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at Patent delisted for Boehringer Ingelheim drug OFEV
Find your next blockbuster

Get accurate and timely intelligence — in just a few clicks

✓ Free trial

✓ No credit card

 

DrugPatentWatch - Make Better Decisions